ABBV-438
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-438, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM) [Phase 1]